Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes

PURPOSE: Recombinant human erythropoietin (rHuEPO) is known to increase thrombotic risk in patients and might have similar effects in athletes abusing the drug. rHuEPO is prohibited by anti-doping legislation, but this risk has not been investigated thoroughly. This analysis was designed to evaluate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Appl Physiol
Autors principals: Heuberger, Jules A. A. C., Posthuma, Jelle J., Ziagkos, Dimitrios, Rotmans, Joris I., Daniels, Johannes M. A., Gal, Pim, Stuurman, Frederik E., Spronk, Henri M. H., Ten Cate, Hugo, Burggraaf, Jacobus, Moerland, Matthijs, Cohen, Adam F.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340646/
https://ncbi.nlm.nih.gov/pubmed/32537688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00421-020-04419-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars